#alphavirus
EIDD-3525 is a broad-spectrum antiviral against alphavirus infection that targets the nsP4 RNA-dependent RNA polymerase https://www.biorxiv.org/content/10.64898/2026.09.26.754626v1
September 29, 2026 at 4:16 AM
Alphavirus infection triggers selective cytoplasmic translocation of nuclear RBPs with moonlighting antiviral roles
www.cell.com/molecular-ce...
December 6, 2024 at 4:03 AM
The salmon industry's dirty little secret.

So called @rspcaassured
salmon found to be contaminated with Furunculosis, Salmon Gill Poxvirus, Yersinia, Salmonid Alphavirus and Piscine Myocarditis Virus.

How was your Christmas lunch?
January 7, 2025 at 2:22 PM
Our study exploring the evolutionary mechanism of alphavirus opal codon retention is now online! www.science.org/doi/10.1126/...
A conserved opal termination codon optimizes a temperature-dependent trade-off between protein production and processing in alphaviruses
Alphaviruses optimize viral polymerase production and polyprotein processing at distinct temperatures via a premature stop codon.
www.science.org
April 18, 2025 at 10:43 PM
EIDD-3525 is a broad-spectrum antiviral against alphavirus infection that targets the nsP4 RNA-dependent RNA polymerase bioRxivpreprint
EIDD-3525 is a broad-spectrum antiviral against alphavirus infection that targets the nsP4 RNA-dependent RNA polymerase
Mosquito-transmitted alphaviruses, including chikungunya (CHIKV), Mayaro, Eastern equine encephalitis, and Venezuelan equine encephalitis viruses, cause severe arthritic or neurologic disease in humans. There are currently no approved antiviral treatments against alphavirus infection. Here, we report that the purine ribonucleoside EIDD-3525 is a potent inhibitor of alphavirus replication in vitro with broad spectrum antiviral activity against the Alphavirus genus. Using a trans-replicase assay, we find that EIDD-3525 blocks alphavirus RNA replication. Mutational profiling suggests that EIDD-3525 targets the alphavirus nsP4 RNA-dependent RNA polymerase that is conserved across medically important alphaviruses. In a pre-clinical mouse model of CHIKV infection and disease, oral treatment with EIDD-3525 reduced viral tissue burdens and the severity of virus-induced disease. Collectively, our findings support the continued development of the purine ribonucleoside EIDD-3525 as an orally available antiviral therapeutic for use against a broad group of alphaviruses.
dlvr.it
September 29, 2026 at 4:31 AM
New preprint alert! 🦟 <-> 🦠 <-> 🧑

I am thrilled to share our latest study on alphavirus host adaptation. More specifically, on how a single codon helps blunt alphavirus-induced host innate immune responses in mosquito and human cells. Continue reading for more!

www.biorxiv.org/content/10.1...
The Sindbis virus nsP3 opal codon protects viral RNA and fitness by maintaining replication spherule integrity
Most alphaviruses encode an in-frame opal stop codon between nsP3 and nsP4 in their nsP ORF. This opal stop codon mediates a temperature-dependent balance between viral polymerase production and prote...
www.biorxiv.org
September 29, 2025 at 11:23 AM
Although I am incredibly sad to miss ASV this year, I am very excited to have Tiia Freeman present our ongoing work on alphavirus evolution in @harmitmalik.bsky.social lab! 🦠🦟🌡️🧬
July 13, 2025 at 7:21 PM
Last seminar in the series with latest insights from Jonathan Abraham's team - #alphavirus-fest 🤓
Final seminar before summer break is #Jonathan_Abraham from @harvardmed.bsky.social

With several key recent discoveries on #alphavirus receptor interactions, this is one not to miss.

THURSDAY 19th JUNE.

Re-post to help spread the word. Email to get a #Zoom link. 🙂
June 12, 2025 at 9:50 AM
New research article

Safety and immunogenicity of an adjuvanted #chikungunya virus virus-like particle ( #CHIKV VLP) vaccine in previous recipients of other alphavirus vaccines versus alphavirus vaccine-naive controls

www.thelancet.com/journals/lan...

#IDSky #ViroSky #ClinMicro #OpenAccess #OA
February 12, 2025 at 4:02 PM
EIDD-3525 is a broad-spectrum antiviral against alphavirus infection that targets the nsP4 RNA-dependent RNA polymerase https://www.biorxiv.org/content/10.64898/2026.09.26.754626v1
September 29, 2026 at 4:16 AM
Our plenary speaker kicking off the Arbovirology session A/Prof Jody Hobson-Peters talking about the insect specific alphavirus (Yada yada virus) and insect specific flaviviruses (Binjari virus) and using reverse genetics approaches to generate vaccines and diagnostics. #AVS12
December 3, 2024 at 4:34 AM
However, we propose an adaptive mechanism through which some alphavirus lineages are actually able to tolerate the loss of the opal codon.
April 18, 2025 at 10:43 PM
Presenting our poster on programming oncolytic alphavirus replicons with immunogenic signals at the Dutch Annual Virology symposium #DAVS2025 in #sunny Utrecht 🌞
March 21, 2025 at 11:40 AM
Programming alphavirus with IFN-γ overrides the adverse effects of macrophages on oncolytic virotherapy https://www.biorxiv.org/content/10.1101/2025.02.12.637841v1
February 17, 2025 at 3:17 AM
#Chikungunya #virus is a #mosquito-borne #alphavirus found in tropical and subtropical regions, with disease characterized by fever and disabling joint symptoms.

📊 Learn more about transmission, diagnosis, management, and prevention in this JAMA Insights.

ja.ma/4wvyvC0
May 13, 2026 at 3:45 PM
Interested in arboviruses? Check out our lab's review on alphavirus nsP3! Combining functions like a Swiss Army knife, this viral protein serves as a critical hub for host interactions, being essential for virus replication and driving virus versatility in subverting mosquito and vertebrate cells.
Alphavirus nsP3 as a multifunctional orchestrator of virus-host interplay | Journal of Virology
Alphaviruses are enveloped, positive-sense RNA viruses in the Togaviridae family and Alphavirus genus (1, 2). They are transmitted mainly by mosquitoes, which become infected while feeding on a viremic vertebrate host and later transmit the virus during subsequent blood meals (3). For a successful transmission cycle, the virus must replicate in both the mosquito and the vertebrate host. Alphaviruses infect a broad range of vertebrates, including humans, other mammals, birds, fish, and reptiles (4, 5). Their emergence, defined as the first appearance or spread into new regions, and reemergence, a resurgence after a period of decline (6), pose an increasing threat to public and animal health, as well as a substantial economic burden (7, 8). Alphaviruses are classified by the type of disease caused. Encephalitic alphaviruses include Venezuelan, western, and eastern equine encephalitis viruses (VEEV, WEEV, and EEEV). Arthritogenic alphaviruses include Chikungunya virus (CHIKV), o'nyong-nyong virus (ONNV), and Ross River virus (RRV) (1), among others.
journals.asm.org
June 16, 2026 at 1:15 AM
nsP3-FXR co-condensation enables alphavirus replication and reveals a targetable alphavirus vulnerability
nsP3-FXR co-condensation enables alphavirus replication and reveals a targetable alphavirus vulnerability
Xie and Cao et al. show that nsP3-FXR condensation is crucial for VEEV replication. UBAP2L is identified as a nsP3-FRX condensate-resident restriction factor that suppresses VEEV replication. Targeting conserved nsP3 AUD via RING-bait technology offers a broad-spectrum antiviral strategy against multiple alphaviruses.
dlvr.it
June 22, 2026 at 11:24 PM
After a long road, it's finally out: Mimicking superinfection exclusion disrupts alphavirus infection and transmission in the yellow fever mosquito Aedes aegypti www.pnas.org/doi/10.1073/...
September 6, 2023 at 12:13 PM
Alphavirus (2026)

⠈⠛⢿⣶⣤⣤⣤⣀⣀⠴⠇⠈⢀⣀⣠⣤⣤⡉⠛⠋⣤⡘⠋⠀⠀⢀⣠⣤⣄⣠⣤⡴⠂
⠀⠀⠀⠀⠀⠀⠉⠛⠛⢿⣿⡿⠀⣰⣾⡿⠟⠛⠛⠛⢿⣷⣄⠈⣵⣤⣤⣶⣿⠟⠛⠻⠛⠙⠀⠀
⠀⠀⠀⠀⠠⢤⣤⣤⠀⢀⣉⠁⣼⣿⠋⣠⣶⣿⣿⣷⣄⠙⣿⣆⠘⠿⠟⠋⠁⠀⠀⠀⠀⠀⠀⠀
⠀⠀⠈⣿⣿⣁⡈⠹⣿⡇⢻⣿⠀⠺⠆⠀⣶⠶⠦
⠀⠀⠀⠀⠀⠀⠀⢀⣴⠟⠀⠀⣿⣿⣿⣷⣶⣶⣾⡿⠟⠋⢀⣤⠈⠉⠉⠉⠁⠀⠛⠿⣶⣤⣄⡀
⠀⠀⠀⠀⠀⠀⠀⠈⠀⠀⠀⢸⣿⡟⠁⠀⣥⡁⢠⣤⣴⣶⠀⠁⢶⣆⠀⠀⠀⠀
⠀⠀⠀⠀⠀⠀⠀⠀⢀⣌⠀⠈⣿⣿
⠉⠃⠀⠀⠀⠀⠀⠀⠀⠀⠀
⠀⠀⠀⠀⠀⠀⠀⠀⠀⠀⣼⣿⠋⠀⠀⠰⠗⠀⠀
⠀⠀⠀⠀⠀⠀⠀⠀⠀⠀⠀⠀⠀⠀⠀⠀⠀⠀⠀⠀⠀⠀⠘⠅⠀⠀⠀⠀⠀⠀⠀⠀⠀⠀⠀⠀
June 8, 2026 at 7:20 PM
Zoom seminar:
Drawing on recent mechanistic and genetic studies, Prof Andres Merits' talk will highlight how #alphavirus #replication complex function intersects with innate #immune sensing and restriction, offering fresh perspectives on virus–host co-evolution and antiviral targeting. All welcome!
January 13, 2026 at 8:01 AM
To round out our Arbovirus session, Mikaela Bell (UQ) is giving us a primer on the ISVac platform Recombinant Alphavirus Based On The Australian Insect-Specific Yada Yada Virus. An incredible story of recovering a virus from metagenomics and then spinning it out to a vaccine platform. #AVS12
December 3, 2024 at 5:48 AM
Dicer accumulates in cytoplasmic foci upon alphavirus infection and plays a proviral role in Myotis myotis bat cells

www.biorxiv.org/content/10.1...
Dicer accumulates in cytoplasmic foci upon alphavirus infection and plays a proviral role in Myotis myotis bat cells
Bats are reservoirs for many viruses that frequently cause epidemics in humans and animals. It is thus critical to better understand their immune system and mechanisms of antiviral immunity. Despite a...
www.biorxiv.org
July 28, 2025 at 9:45 PM
Second last in the arbovirus session is our first #alphavirus talk of the session from Jennifer Hyde (University of Washington) talking about the Contribution of viral RNA structures to cellular tropism and epizootic emergence of alphaviruses #AVS12
December 3, 2024 at 5:34 AM
XRN1 supplies free nucleotides to feed alphavirus replication https://www.biorxiv.org/content/10.1101/2024.12.09.625895v1
December 10, 2024 at 2:45 AM